Filter Results:
(1,329)
Show Results For
- All HBS Web
(1,329)
- People (1)
- News (333)
- Research (819)
- Events (1)
- Multimedia (8)
- Faculty Publications (593)
Show Results For
- All HBS Web
(1,329)
- People (1)
- News (333)
- Research (819)
- Events (1)
- Multimedia (8)
- Faculty Publications (593)
- 01 Sep 2010
- News
RX for Change
clinicians need to take responsibility for letting health care get out of their hands and help right the ship in the way health-care systems are being managed. Physicians can not absolve themselves and simply get mad when View Details
- December 2021
- Case
Grace Capital
By: Sara Fleiss, Robin Greenwood, Eren Kuzucu and Denise Han
In March 2020, the global pandemic was delivering a dose of volatility to the U.S. economy. Catherine Faddis, the CIO of Grace Capital, a Boston-based long-only equity manager, analyzed movements in her portfolio while eyeing previously shelved opportunities to invest... View Details
Keywords: Preferred Stock; COVID-19 Pandemic; Economy; Health Pandemics; Volatility; Entrepreneurship; Finance; Investment; Strategy; Decision Making; Investment Portfolio; Financial Services Industry; United States
Fleiss, Sara, Robin Greenwood, Eren Kuzucu, and Denise Han. "Grace Capital." Harvard Business School Case 222-052, December 2021.
- 23 Apr 2020
- Research & Ideas
This Crisis Loan Program Preserved Jobs—and Made Money
more stable career path. The firms themselves also grew stronger, and the French government eventually saved more in unemployment benefits than the program cost, according to the study, Employment Effects of Alleviating Financing... View Details
- 08 Sep 2015
- First Look
September 8, 2015
that exists at the top of organizational hierarchies. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=49601 forthcoming Management Science Financing Risk and Innovation By: Nanda, Ramana, and Matthew Rhodes-Kropf... View Details
Keywords: Carmen Nobel
- Career Coach
Kaitlin Hearn
Kaitlin grew up in Canada and studied engineering, but has spent the bulk of her career in finance and consulting in New York. As a serial career switcher herself, Kaitlin is well positioned to help you think through the merits and... View Details
- Web
Simona Stancov Archives | Social Enterprise
Impact Measurement Inclusive Finance International Development K-12 Education Leadership Fellows Leadership in Challenging Times MBA Programs Microfinance Non Profit Management Nonprofit Supportive Services Public Sector Public-Private... View Details
- July 2017 (Revised July 2019)
- Supplement
"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B)
By: Nori Gerardo Lietz and Ricardo Andrade
The B Case of "Dr. My Eyes" provides the answer as to what happened after the ending fact pattern in Case A and the imminent choices faced by the protagonist in the primary case. At the end of the Case A, Bess Weatherman of Warburg Pincus, must chose one option of two... View Details
Keywords: Private Equity; Health Care and Treatment; Mergers and Acquisitions; Corporate Governance; Decision Choices and Conditions; Outcome or Result; Health Industry; Health Industry; Health Industry
Lietz, Nori Gerardo, and Ricardo Andrade. "Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B). Harvard Business School Supplement 218-029, July 2017. (Revised July 2019.)
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
Bill Bowes (MBA ’52) and Kathy Giusti (MBA ’85) first met in 2009, when they were both honored with HBS’s Alumni Achievement Award. This cross-generational meeting would demonstrate not only the power of serendipity but also the power of HBS to convene remarkable... View Details
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- Profile
Kevin Nazemi
the Harvard Kennedy School “is the best of both worlds. I’m interested in the intersection of business, public policy, and technology, especially in health care. I see HBS as a place where you can dream big, and build the tool sets and... View Details
- 26 Sep 2016
- News
Steward gets $1.25b to fund expansion, repay Cerberus
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
Coleman, acquired the household goods division of American Home Products for $1.3 billion.27 Proceeds from these sales, supplemented by retained earnings, helped to finance the expansion of the company's healthcare businesses. In 1986... View Details
- Web
Work & Life - Race, Gender & Equity
at home [1] 51 Women with children under 18 at home 54 Men with no children at home 54 Men with children under 18 at home Top 5 Industries Hours/Week Women Men Consulting / Professional Services 52 55 Educational Services / Academics 49 53 View Details
- 06 Dec 2021
- News
What's the Word?
number of working women who’ve experienced negative health consequences as a result of the pandemic is 10 to 12 percentage points higher than men. It’s stress, a sense of being overwhelmed, depression—all of the conditions that occur when... View Details
- Article
Treatment Of Opioid Use Disorder Among Commercially Insured U.S. Adults, 2008–17
By: Karen Shen, Eric Barrette and Leemore S. Dafny
There is abundant literature on efforts to reduce opioid prescriptions and misuse, but comparatively little on the treatment provided to people with opioid use disorder (OUD). Using claims data representing 12–15 million nonelderly adults covered through commercial... View Details
Keywords: Opioid Treatment; Medication-assisted Treatment; Substance Use Disorder; Private Insurance; Health Disorders; Health Care and Treatment; Insurance; United States
Shen, Karen, Eric Barrette, and Leemore S. Dafny. "Treatment Of Opioid Use Disorder Among Commercially Insured U.S. Adults, 2008–17." Health Affairs 39, no. 6 (June 2020): 993–1001.
- 24 Apr 2014
- News
Outside-the-box innovation for off-the-grid energy
sustainably. It has substantial advantages over alternatives—and it works!” Through an “Energy as a Service” financing model, even the poorest communities will be able to afford reliable electricity for irrigation, education, View Details
- 09 Jun 2020
- Working Paper Summaries
Aggregate and Firm-Level Stock Returns During Pandemics, in Real Time
- Web
Courses by Faculty Unit - Course Catalog
Operations Management) Suraj Srinivasan Spring 2026 Q4 1.5 Strategy Execution Robert Simons Spring 2026 Q4 1.5 Systems for Scaling Ventures (SSV) (also listed under Entrepreneurial Management) Tatiana Sandino Spring 2026 Q3Q4 3.0 Transforming View Details
- 01 Mar 2010
- News
Sole Mates
Africa; its importance to the country is as great as the threat to its existence. Illegal logging fueled Liberia’s recent civil war: “Blood timber” financed the violence, just as blood diamonds have in other African conflicts. The civil... View Details
- July 2002 (Revised December 2002)
- Case
Phase Two: The Pharmaceutical Industry Responds to AIDS
By: Debora L. Spar
Describes how major pharmaceutical firms changed their strategy and pricing policies in the years 2000 to 2002 to respond to the growing AIDS epidemic in Africa. View Details
Keywords: International Finance; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
Spar, Debora L., and Nick Bartlett. "Phase Two: The Pharmaceutical Industry Responds to AIDS." Harvard Business School Case 703-005, July 2002. (Revised December 2002.)